Clinical Trial Update: A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse [Phase 3]

View source ↗

Summary

This entry describes a Phase III clinical trial evaluating cabazitaxel with pelvic radiotherapy for localized prostate cancer and high-risk relapse features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: UNICANCER | Conditions: Adenocarcinoma of Prostate, Progression of Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING